NCT00311714View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetic Study of Biota-CS-8958

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2007

Study Completion Date

December 31, 2007

Conditions
Influenza
Interventions
DRUG

CS-8958 formulated as dry powder

OTHER

Placebo

Trial Locations (1)

LS2 9LH

Covance Clinical Research Unit Ltd (Covance CRU), Leeds

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Biota Scientific Management Pty Ltd

INDUSTRY

NCT00311714 - Safety, Tolerability and Pharmacokinetic Study of Biota-CS-8958 | Biotech Hunter | Biotech Hunter